Ciprofloxacin resistance in methicillin-and gentamicin-resistantStaphylococcus aureus
- 1 July 1989
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 8 (7) , 622-624
- https://doi.org/10.1007/bf01968141
Abstract
A total of 112Staphylococcus aureus strains resistant to methicillin and gentamicin were collected from 31 centres in 22 countries worldwide. Many strains were multi-resistant. In tests to determine the susceptibility of the organisms to ciprofloxacin 16 strains (14.3%), originating from France, the FRG, Israel and Italy, were shown to be resistant to this agent. To limit ciprofloxacin resistance, a reappraisal is necessary of fluoroquinolone usage against methicillin-and gentamicin-resistantStaphylococcus aureus.This publication has 10 references indexed in Scilit:
- WORLD-WIDE ANTIBIOTIC RESISTANCE IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUSThe Lancet, 1989
- Ciprofloxacin resistance in epidemic methicillin-resistant Staphylococcus aureus.1988
- CIPROFLOXACIN RESISTANCE IN EPIDEMIC METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUSThe Lancet, 1988
- [Course of the resistance of Staphylococcus aureus to pefloxacin. A study based on 782 strains isolated in 1985 and 1986].1988
- Ciprofloxacin for eradication of methicillin-resistant Staphylococcus aureus colonization.1987
- The effect of ciprofloxacin on methicillin-resistant Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1986
- Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1985